Quantifying the health benefits of genetic tests: The importance of a population perspective

被引：25

作者：

Khoury, MJ

Jones, K

Grosse, SD

机构：

[1] Ctr Dis Control & Prevent, Off Genom & Dis Prevent, Coordinat Ctr Hlth Promot, Atlanta, GA 30341 USA

[2] Ctr Dis Control & Prevent, Div Publ Private Partnerships, Natl Ctr Hlth Mkt, Coordinat Ctr Hlth Informat Serv, Atlanta, GA USA

[3] Ctr Dis Control & Prevent, Coordinat Ctr Hlth Promot, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA

来源：

GENETICS IN MEDICINE | 2006年 / 8卷 / 03期

关键词：

D O I：

10.1097/01.gim.0000206278.37405.25

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：191 / 195

页数：5

共 26 条

[11] An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions [J].

Khoury, MJ ;

Yang, QH ;

Gwinn, M ;

Little, JL ;

Flanders, WD .

GENETICS IN MEDICINE, 2004, 6 (01) :38-47

[12] Genomic medicine - Population screening in the age of genomic medicine. [J].

Khoury, MJ ;

McCabe, LL ;

McCabe, ERB .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :50-58

[13] Diabetes and all-cause and coronary heart disease mortality among US male physicians [J].

Lotufo, PA ;

Gaziano, JM ;

Chae, CU ;

Ajani, UA ;

Moreno-John, G ;

Buring, JE ;

Manson, JE .

ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (02) :242-247

[14] Methods for priority setting among clinical preventive services [J].

Maciosek, MV ;

Coffield, AB ;

McGinnis, JM ;

Harris, JR ;

Caldwell, MB ;

Teutsch, SM ;

Atkins, D ;

Richland, JH ;

Haddix, H .

AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2001, 21 (01) :10-19

[15] An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics [J].

Phillips, KA ;

Veenstra, D ;

Van Bebber, S ;

Sakowski, J .

PHARMACOGENOMICS, 2003, 4 (03) :231-239

[16] SICK INDIVIDUALS AND SICK POPULATIONS [J].

ROSE, G .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1985, 14 (01) :32-38

[17]

RYAN S, 2004, GENEREVIEW

[18]

Scheuner MT, 1997, AM J MED GENET, V71, P315, DOI 10.1002/(SICI)1096-8628(19970822)71:3<315::AID-AJMG12>3.0.CO

[19]

2-N

[20]

Veenstra DL, 2000, AAPS PHARMSCI, V2, part. no.

← 1 2 3 →